View on Pubmed.gov 12120282 | View on doi.org 10.1038/nrd773
Protein kinases--the major drug targets of the twenty-first century?
- Medical Research Council, Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK. p.cohen@dundee.ac.uk
Abstract
Protein phosphorylation regulates most aspects of cell life, whereas abnormal phosphorylation is a cause or consequence of disease. A growing interest in developing orally active protein-kinase inhibitors has recently culminated in the approval of the first of these drugs for clinical use. Protein kinases have now become the second most important group of drug targets, after G-protein-coupled receptors. Here, I give a personal view of some of the most important advances that have shaped this field.
References
Cited by 568 citations (total)
Journal Article Research Support, N.I.H., Extramural
Using substrate-binding variants of the cAMP-dependent protein kinase to identify novel targets and a kinase domain important for substrate interactions in Saccharomyces cerevisiae.
Electronic publication date November 14, 2006
Stephen J Deminoff [...] Paul K Herman et al.
Protein kinases mediate much of the signal transduction in eukaryotic cells and defects in kinase function are associated with a...
Journal Article Review
Targeting cancer with small molecule kinase inhibitors.
Electronic publication date January 8, 2009
Jianming Zhang [...] Nathanael S Gray et al.
Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiological constraints on growth...
Conflict of interest statement
MeSH
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •